Clinical Trial Update: Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin [Phase 1]

View source ↗

Summary

Phase 1 trial assessing induction therapy with 131I-MIBG plus chemotherapy for newly diagnosed high-risk neuroblastoma patients undergoing stem cell transplant,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglioneuroblastoma
• Neuroblastoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)
• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Children's Oncology Group | Conditions: Ganglioneuroblastoma, Localized Resectable Neuroblastoma | Phase 1 | Status: COMPLETED | Results posted: 2017-09-28